Serendo therapeutics AB is a Swedish AB based in Helsingborg, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2024, the company reported revenue of SEK 108.1k in its latest annual filing.
In its most recent annual report (2025), Serendo therapeutics AB reported revenue of SEK 108.1k. The bottom line showed a net profit of SEK 11.0k, and the EBITDA margin stood at 12.8%.
At the end of 2025, equity financed 55.1% of the balance sheet, and current assets covered short-term debt 2.2 times.
Frequently asked questions
What is the Org number of Serendo therapeutics AB?
Serendo therapeutics AB is registered with Bolagsverket / SCB under Org 5595116731.
What is the revenue of Serendo therapeutics AB?
Serendo therapeutics AB reported revenue of SEK 108.1k in 2025.
Where is Serendo therapeutics AB headquartered?
Serendo therapeutics AB's registered address is Norra Kustvägen 20.
